248 related articles for article (PubMed ID: 12730676)
1. Intracellular mediators of erucylphosphocholine-induced apoptosis.
Jendrossek V; Müller I; Eibl H; Belka C
Oncogene; 2003 May; 22(17):2621-31. PubMed ID: 12730676
[TBL] [Abstract][Full Text] [Related]
2. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
3. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Suliman A; Lam A; Datta R; Srivastava RK
Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
[TBL] [Abstract][Full Text] [Related]
4. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
[TBL] [Abstract][Full Text] [Related]
5. The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis.
Chen CY; Juo P; Liou JS; Li CQ; Yu Q; Blenis J; Faller DV
Cell Growth Differ; 2001 Jun; 12(6):297-306. PubMed ID: 11432804
[TBL] [Abstract][Full Text] [Related]
6. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
Lawrence CP; Chow SC
FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
[TBL] [Abstract][Full Text] [Related]
7. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
8. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
Wang P; Song JH; Song DK; Zhang J; Hao C
Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
[TBL] [Abstract][Full Text] [Related]
9. Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3.
Guseva NV; Taghiyev AF; Rokhlin OW; Cohen MB
Prostate; 2002 Jun; 51(4):231-40. PubMed ID: 11987151
[TBL] [Abstract][Full Text] [Related]
10. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
Izeradjene K; Douglas L; Delaney AB; Houghton JA
Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
[TBL] [Abstract][Full Text] [Related]
11. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis.
Belka C; Rudner J; Wesselborg S; Stepczynska A; Marini P; Lepple-Wienhues A; Faltin H; Bamberg M; Budach W; Schulze-Osthoff K
Oncogene; 2000 Feb; 19(9):1181-90. PubMed ID: 10713706
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.
von Haefen C; Wieder T; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2003 Apr; 22(15):2236-47. PubMed ID: 12700660
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 mediated inhibition of erucylphosphocholine-induced apoptosis depends on its subcellular localisation.
Handrick R; Rudner J; Müller I; Eibl H; Belka C; Jendrossek V
Biochem Pharmacol; 2005 Sep; 70(6):837-50. PubMed ID: 16083863
[TBL] [Abstract][Full Text] [Related]
14. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ
Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
Jendrossek V; Handrick R; Belka C
FASEB J; 2003 Aug; 17(11):1547-9. PubMed ID: 12824303
[TBL] [Abstract][Full Text] [Related]
16. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway.
Scholz C; Richter A; Lehmann M; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2005 Oct; 24(47):7031-42. PubMed ID: 16007134
[TBL] [Abstract][Full Text] [Related]
18. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
20. Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway.
Verbrugge I; de Vries E; Tait SW; Wissink EH; Walczak H; Verheij M; Borst J
Oncogene; 2008 Jan; 27(5):574-84. PubMed ID: 17684487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
